DiaSorin S.p.A. (BIT:DIA)

Market Cap	5.06B
Revenue (ttm)	1.19B
Net Income (ttm)	187.00M
Shares Out	53.32M
EPS (ttm)	n/a
PE Ratio	27.07
Forward PE	21.44
Dividend	1.20 (1.26%)
Ex-Dividend Date	May 19, 2025

Volume	94,559
Average Volume	165,707
Open	95.22
Previous Close	95.58
Day's Range	94.92 - 95.76
52-Week Range	82.72 - 112.35
Beta	0.16
RSI	39.66
Earnings Date	Mar 14, 2025

About DiaSorin

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic LIAISON chemiluminescence analyzers under LIAISON XL and LIAISON XS name; and Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. The company was founded in 1968 and is headquartered in Saluggia, Italy.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1968
• Employees: 3,233
• Stock Exchange: Borsa Italiana
• Ticker Symbol: DIA

Financial Performance

In 2024, DiaSorin's revenue was 1.19 billion, an increase of 3.20% compared to the previous year's 1.15 billion. Earnings were 187.00 million, an increase of 16.99%.